Related Experiment Video
Updated: May 25, 2026
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
An Open Access future? Report from the eurocancercoms project
1European Association for Cancer Research, EACR Secretariat, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK.
Ecancermedicalscience
|January 26, 2012
Summary
Cancer researchers strongly favor Open Access publishing. A survey found 88% believe publicly funded research should be freely accessible, supporting faster progress in cancer research.
Area of Science:
- Cancer Research
- Scholarly Communication
- Bibliometrics
Background:
- The European Association for Cancer Research (EACR) surveyed members in March 2011.
- This research was part of the FP7 Eurocancercoms project.
- The survey explored attitudes towards academic publishing and Open Access.
Purpose of the Study:
- To assess European cancer researchers' experiences and attitudes regarding academic publishing.
- To compare EACR survey findings with the larger Study of Open Access Publishing (SOAP) data.
- To contribute to the ongoing debate on Open Access versus subscription publishing models.
Main Methods:
- An online survey was distributed to EACR members across Europe.
- Results were analyzed and compared with data from the Study of Open Access Publishing (SOAP).
Main Results:
- Both surveys indicated highly positive attitudes towards Open Access publishing.
- A significant finding was that 88% of EACR respondents believe public research should be accessible without barriers.
- This highlights strong support for Open Access within the cancer research community.
Conclusions:
- The findings support accelerating the transition to Open Access for cancer research publications.
- Open Access publishing is presented as a means to facilitate unhindered research progress.
- The study advocates for wider adoption of Open Access to benefit the research community.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...